GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » EV-to-FCF

PharmaRoth Labs (PharmaRoth Labs) EV-to-FCF : 0.00 (As of May. 21, 2024)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PharmaRoth Labs's Enterprise Value is $0.00 Mil. PharmaRoth Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2011 was $-0.15 Mil. Therefore, PharmaRoth Labs's EV-to-FCF for today is 0.00.

The historical rank and industry rank for PharmaRoth Labs's EV-to-FCF or its related term are showing as below:

ROTH's EV-to-FCF is not ranked *
in the Biotechnology industry.
Industry Median: 8.34
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), PharmaRoth Labs's stock price is $0.0001. PharmaRoth Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2011 was $-0.004. Therefore, PharmaRoth Labs's PE Ratio for today is At Loss.


PharmaRoth Labs EV-to-FCF Historical Data

The historical data trend for PharmaRoth Labs's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs EV-to-FCF Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
EV-to-FCF
- -3,400.00 -276.04

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaRoth Labs's EV-to-FCF

For the Biotechnology subindustry, PharmaRoth Labs's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaRoth Labs's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaRoth Labs's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where PharmaRoth Labs's EV-to-FCF falls into.



PharmaRoth Labs EV-to-FCF Calculation

PharmaRoth Labs's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.000/-0.147
=0.00

PharmaRoth Labs's current Enterprise Value is $0.00 Mil.
PharmaRoth Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaRoth Labs  (GREY:ROTH) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PharmaRoth Labs's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0001/-0.004
=At Loss

PharmaRoth Labs's share price for today is $0.0001.
PharmaRoth Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


PharmaRoth Labs EV-to-FCF Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines